{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457138752
| IUPAC_name = 4-[(1''R'')-1-hydroxy-2-<nowiki/>{[4-(4-hydroxyphenyl)butyl]amino}ethyl]benzene-1,2-diol
| image = Arbutamine.svg
| width = 250

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 128470-16-6
| ATC_prefix = C01
| ATC_suffix = CA22
| PubChem = 60789
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01102
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54785
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = B07L15YAEV
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50580
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201251

<!--Chemical data-->
| C=18 | H=23 | N=1 | O=4
| molecular_weight = 317.38 g/mol
| smiles = Oc1ccc(cc1O)[C@@H](O)CNCCCCc2ccc(O)cc2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C18H23NO4/c20-15-7-4-13(5-8-15)3-1-2-10-19-12-18(23)14-6-9-16(21)17(22)11-14/h4-9,11,18-23H,1-3,10,12H2/t18-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = IIRWWTKISYTTBL-SFHVURJKSA-N
}}

'''Arbutamine''' is a [[cardiac stimulant]]. It stimulates β [[adrenergic receptor]]s.<ref name="pmid8723169">{{cite journal|last1=Abou-Mohamed|first1=Gamal|last2=Nagarajan|first2=Ravi|last3=Ibrahim|first3=Tarek M.|last4=Caldwell|first4=Robert W.|title=Characterization of the Adrenergic Activity of Arbutamine, a Novel Agent for Pharmacological Stress Testing|journal=Cardiovascular Drugs and Therapy|date=March 1996|volume=10|issue=1|pages=39–47|doi=10.1007/BF00051129|pmid=8723169}}<!--|accessdate=6 March 2016--></ref>

==References==
{{reflist}}

{{Adrenergic agonists}}
{{Cardiac stimulants excluding cardiac glycosides}}

[[Category:Beta-adrenergic agonists]]
[[Category:Catecholamines]]
[[Category:Cardiac stimulants]]

{{cardiovascular-drug-stub}}